Sun.Mar 10, 2024

article thumbnail

Momentum behind hospital-at-home continues to grow, but proponents say Congress needs to act to fuel more investment

Fierce Healthcare

LAS VEGAS — Francisco Dizon, 77 years old, sat comfortably in his living room as a team of clinicians took his vital signs and administered IV medications to treat his urinary tract infection. | The American Medical Association and the American Telemedicine Association joined major health systems like Geisinger, John Hopkins and Mass General Brigham along with health tech companies to call for Congressional support for the future of home-based care.

article thumbnail

Is AI an Existential Risk? Q&A with RAND Experts

The Rand Blog

What are the potential risks associated with AI? Might any of these be catastrophic or even existential? And as momentum builds toward boundless applications of this technology, how might humanity reduce AI risk and navigate an uncertain future?

111
111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

HIMSS24: Healthcare continues to make gains in data exchange with 49% jump in electronic prior authorization

Fierce Healthcare

ORLANDO, Florida—The industry continues to make substantial gains in health data exchange and interoperability, according to new data released by health information network Surescripts. | ORLANDO, Florida—The industry continues to make substantial gains in health data exchange and interoperability, according to new data released by health information network Surescripts.

article thumbnail

Bot Docs? 69% of Patients Uncomfortable with AI Diagnosing Them

HIT Consultant

What You Should Know: – While healthcare has embraced wearables and virtual visits, a new survey reveals that 69% of U.S. adults are uncomfortable with healthcare companies using AI to diagnose them. – Salesforce’s Pulse of the Patient Snapshot surveyed over 1,400 U.S. adults revealed patients do not want to see doctors replaced with AI.

Doctors 105
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Monday Morning Update 3/11/24

HIStalk

Top News UnitedHealth Group hopes to restore Change Healthcare’s electronic.

75
article thumbnail

Intermountain Health Achieves World’s First INFRAM24 Stage 7 Validation

HIT Consultant

What You Should Know: – Intermountain Health has reached a monumental achievement, becoming the first organization in the world to be recognized as a Quadruple Stage 7 Healthcare Organization by the Healthcare Information and Management Systems Society (HIMSS). – The milestone signifies Intermountain’s unwavering commitment to pioneering excellence in healthcare infrastructure and technology.

More Trending

article thumbnail

Israeli Life Science Industry Shows Resilience Despite Funding Slowdown

HIT Consultant

What You Should Know: – The Israel Advanced Technologies Institute (IATI ), in partnership with PwC and the Israel Innovation Authority, unveiled its annual Life Science Industry report at the MIXiii Health-Tech.IL conference. – The report underlines the Israeli life sciences sector’s resilience, unity, and determination to keep operating, innovating, and delivering crucial solutions.

article thumbnail

Lexaria Conducts Second Human Trial for Improved Oral GLP-1 Delivery

HIT Consultant

What You Should Know: – Lexaria Bioscience Corp. is pushing the boundaries of oral drug delivery with their latest clinical trial. – The company announced they have contracted a research organization (CRO) to conduct a second human pilot study on their DehydraTECH-powered glucagon-like peptide-1 (GLP-1) treatment. GLP-1 Challenges and Lexaria’s Solution GLP-1 drugs, like semaglutide, are currently delivered through injections or tablets.